Open your free All-in-One trading account with zero hassle!
Tata India Pharma & Healthcare Fund
Sectoral-PharmaRank #27
2/5
NAV (2026-09-11)
₹33.19
AUM
₹1,565.28 Cr
Exp. Ratio: 2.37%
RISK LEVEL
Very High
Returns & Performance
1 Year7.09%8.04% vs cat avgRank #26
3 Year17.92%2.81% vs cat avgRank #14
5 Year12.90%1.04% vs cat avgRank #8
Since Launch11.85%5.28% vs cat avg
Fund vs Category Average
1Y
7.09%-8.04%
3Y
17.92%-2.81%
5Y
12.90%-1.04%
Pros & Cons
Pros
✔No lock-in period
Cons
✖1Y returns trail category average
✖3Y returns below category average
✖5Y returns below category average
✖Higher expense ratio (2.37%)
✖1Y category rank outside top 15 (#26)
✖Overall rank #27 in category
✖Returns since launch below category avg
ISININF277K016A9
NAV₹33.19
NAV Date2026-09-11
AUM₹1,565.28 Cr
Expense Ratio2.37%
RiskVery High
Rating2 / 5
Min SIP Amount₹100
Max SIP Amount₹999999999
Min Additional Inv.₹1000
SIP AllowedYes
Plan TypeRegular
Plan OptionGrowth
Is NFONo
Fund House Incorp.1995-06-30
INVESTMENT OBJECTIVE
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Exit Load0.25%
Stamp duty on investment0.005% (from July 1st, 2020)
Tax implicationsIf you redeem within one year, your returns will be taxed at 20%. For redemptions after one year, returns exceeding ₹1.25 lakh in a financial year will be taxed at 12.5%.
Rajat Srivastava
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Common questions about this fund, answered from scheme data
The latest Net Asset Value (NAV) of Tata India Pharma & Healthcare Fund is ₹33.19 as of 2026-09-11.
Tata India Pharma & Healthcare Fund is classified as a Sectoral-Pharma fund.
Tata India Pharma & Healthcare Fund is managed by Tata Mutual Fund.
The Assets Under Management (AUM) of Tata India Pharma & Healthcare Fund is ₹1,565.28 Cr.
The expense ratio of Tata India Pharma & Healthcare Fund is 2.37%.
Tata India Pharma & Healthcare Fund is managed by Rajat Srivastava.
The minimum SIP investment for Tata India Pharma & Healthcare Fund is ₹100.
The exit load for Tata India Pharma & Healthcare Fund is 0.25%.
As per the SEBI Riskometer, Tata India Pharma & Healthcare Fund carries a Very High risk level.
Tata India Pharma & Healthcare Fund has delivered 7.09% (1Y), 17.92% (3Y) and 12.9% (5Y) annualised returns as of 2026-09-11.
Tata India Pharma & Healthcare Fund was launched on 1995-06-30.
Open an account with Indiabulls Securities, complete your KYC, and invest via SIP or a one-time lumpsum through our platform.
A Systematic Investment Plan (SIP) lets you invest a fixed amount at regular intervals (e.g., monthly) instead of a single lumpsum.
There is no separate brokerage on mutual fund units. The AMC charges an expense ratio, which is already reflected in the NAV. An exit load may apply if you redeem before the specified period.
Mutual fund NAVs are declared once per business day after market close, in line with SEBI norms.
The FAQs above are generated from data provided by the AMC and are for educational purposes only. They do not constitute financial advice, buy/sell recommendations, or return guarantees. Mutual fund investments are subject to market risks — read all scheme-related documents carefully before investing. Past performance is not indicative of future returns.
